global business & strategy


global business & strategy

global development

The main thrust is to raise price competitiveness by improving manufacturing efficiency, carefully choosing our target markets and the dominating the market by launching the products as first generic drugs in the major markets including Latin America, USA, Asia, Middle East, Africa and Europe.
Huons has been producing Local Anesthesia as mayor product and others, supplying it to more than 900 customers in over 32 countries all over the world.

Our current focusing area and stragth lie with Urology Orthopedic Surgery, Anti-Arthritis, Anesthetics, Natural Well-Being Products including Anti-Obesity, Gynecology and related Women's Health and Dental Care. We intend to further diversity the potential product portfolio.

In this regards, we are searching for new business alliance with Potent new drug candidates, collaborative R&D in-licensing activities including diagnostics and medical devices.

achievement

The main thrust is to raise price competitiveness by improving manufacturing efficiency, carefully choosing our target markets and the dominating the market by launching the products as first generic drugs in the major markets including Latin America, USA, Asia, Middle East, Africa and Europe.

global business

The main thrust is to raise price competitiveness by improving manufacturing efficiency, carefully choosing our target markets and the dominating the market by launching the products as first generic drugs in the major markets including Latin America, USA, Asia, Middle East, Africa and Europe.
Huons has been producing Local Anesthesia as mayor product and others, supplying it to more than 900 customers in over 32 countries all over the world.

Huons has been supplying to customer in :
- Europe :
UK, Poland, Italy, Rumania, ETC
- Asia :
Japan, China, Pakistan, Indonesia, Philipine, Vietnam, Thailand, ETC
- Middle East :
Yemen, Jordan, Syria, Irq, Lebanon, ETC
- America :
USA, The most countries of Central America and South America.

Huons also has been actively worked with global partners in exporting Medical Device products such as SPRP Kit, Dermashine (Derma injector), Filler, cosmetics, etc.

increase of exportation with good quality of production

First time in Korea developed disposible Eye Drops using hyaluronic acid as raw material, and adoped the control quality standard of advanced countries from Alcon (Kynex 1- Eye drops) and additional agreement with Kynex 2 with same company.The contract between Huons Co., Ltd. and US company has been perfomed for Lidocaine HCl 1% Inj. for ANDAs by US-FDA. Joint venture company incorporation agreement with Beijing Huonland Medical Tech Co., Ltd.

Huons is advancing beyond its leading position at home to take its place on the world stage. While sharpening our competitive edge in the domestic pharmaceutical market, we will solidify our position in Latin America, USA, Asia, Middle East, Africa and Europe. Ultimately, we will achieve true globalization by forming strategic alliances and entering advanced markets side by side with top-tier multinational pharmaceutical player.

To the first Open CYBERTOUR when you clicked Open Commercial video when you clicked